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Abstract
Corticoids are well known for their immunosuppressive properties. Interleukin-10 (IL-10) is
an intrinsic antiinflammatory peptide in immune diseases, originally identified as cytokine syn-
thesis inhibitory factor. We examined the effect of hydrocortisone sodium succinate (HSS) on
the production of IL-10 by human peripheral blood mononuclear cells (PBMCs). PBMCs from
healthy volunteers and cancer-burden patients were preincubated separately with or without HSS
for 1 h, then stimulated with 5 microg/ml lipopolysaccharide (LPS). Production of IL-10 by human
PBMCs was detected with LPS stimulation and its production was higher in cancer-burden patients
than in normal volunteers, although this was not statistically significant. HSS suppressed produc-
tion of IL-10 by LPS-stimulated PBMCs in a dose-dependent manner both in normal volunteers
and in cancer-burden patients. These results indicate that, in addition to their antiinflammatory
properties, corticoids act to restore the immunosuppressive states even in cancer-burden states
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